Latest News

  • Concordia International Corp. Announces NASDAQ Delisting

    Concordia International Corp. today announced that as a result of the Company's decision not to submit a plan to regain compliance with NASDAQ Global Select Market's ("Nasdaq") continued listing requirements, which decision was announced by Concordia in a press release on May 31, 2018, Nasdaq announced yesterday its determination to delist the Company's securities from Nasdaq.

    Read More

    Tagged

    • Pharmaceutical
  • Recruitment Scams

    Recent incidents have occurred involving person(s) falsely claiming to recruit on behalf of Concordia. Please note that Concordia or its group/subsidiary companies does not (nor do any of the organizations that recruit on our behalf) permit any unauthorized recruitment and in the process do not seek or provide money or payments

    Read More

    Tagged

    • Business
  • Concordia Obtains Final Court Order Approving its Recapitalization Transaction and Announces Leadership Changes

    Concordia International Corp. today announced that in connection with the previously announced recapitalization transaction described in the Company's management information circular dated May 15, 2018, the Company has obtained a final court order from the Ontario Superior Court of Justice approving the plan.

    Read More

    Tagged

    • Pharmaceutical
  • Approval of CBCA Plan of Arrangement by Its Shareholders and Debtholders

    Concordia International Corp. announced that at the meetings of holders of certain secured debt of Concordia (the "Secured Debtholders") and holders of certain unsecured debt of Concordia (the "Unsecured Debtholders") and at the annual and special meeting of shareholders of Concordia.

    Read More

    Tagged

    • Pharmaceutical
  • Amendments to CBCA Plan of Arrangement in Connection with its Recapitalization Transaction

    Concordia International Corp. announced today that, in connection with the previously announced proposed recapitalization transaction described in the Company's management information circular dated May 15, 2018 and to be implemented pursuant to a plan of arrangement (the "CBCA Plan") under the Canada Business Corporations Act.

    Read More

    Tagged

    • Pharmaceutical